Contribution of mast cells and snake venom metalloproteinases to the hyperalgesia induced by Bothrops jararaca venom in rats.

Laboratory of Inflammation, Department of Physiology and Pharmacodynamics, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Av. Brasil, CEP 21040-900, 4365 Rio de Janeiro, Brazil.
Toxicon (Impact Factor: 2.58). 07/2006; 47(8):885-93. DOI: 10.1016/j.toxicon.2006.02.017
Source: PubMed

ABSTRACT Bothrops jararaca venom (Bjv) is known to induce local inflammation and severe pain. Since, mast cells are able to secrete mediators involved in algesic processes, in this study we examined the putative role of these cells in the hyperalgesia triggered by Bjv in the rat paw. We noted that treatment with mast cell stabilizer sodium cromoglicate as well as with histamine and 5-hydroxytriptamine receptor antagonists meclizine and methysergide, respectively, inhibited the Bjv-induced hyperalgesia. In addition, we showed that stimulation of isolated rat peritoneal mast cells with Bjv in vitro resulted in the release of stored and neo-generated inflammatory mediators such as histamine and leukotriene C(4), respectively. Bjv-induced histamine secretion was clearly sensitive to treatment with sodium cromoglicate and sodium nedocromil. We further observed that metalloproteinase inhibitors 1,10-phenantroline and DM43 inhibited mast cell degranulation in vitro, under conditions where inhibitors of phospholipase A(2) as well as of serine- and cysteine-proteinases were inactive. Altogether, our findings indicate that mast cells seem to contribute to the hyperalgesia caused by Bjv in the rat paw, and also provide evidence that this response might be dependent on the ability of the Bjv to activate directly mast cells.

  • [Show abstract] [Hide abstract]
    ABSTRACT: While previous studies suggest that snake venom contains glycan-binding proteins (GBPs), the binding specificity and biological activities of many of these GBPs remains unknown. In order to more fully characterize the glycan binding activity and biological activity of snake venom GBPs, we evaluated the glycan binding specificity of galatrox, a Bothrops atrox snake venom-derived GBP. Glycan microarray analysis indicates that galatrox binds strongly to glycans expressing N-acetyllactosamine (LacNAc), with a significant preference for Galβ1-4GlcNAcβ over Galβ1-3GlcNAcβ compounds. Galatrox also bound immobilized laminin, a LacNAc-dense extracellular matrix component, suggesting that this GBP possess the capacity to recogonize LacNAc bearing glycoproteins. As several endogenous mammalian GBPs utilize a similar binding preference to regulate neutrophil and monocyte activity, we hypothesized that galatrox may, in part, mediate Bothrops atrox toxicity through regulation of leukocyte activity. Indeed, galatrox recognized neutrophils and promoted leukocyte chemotaxis in a carbohydrate-dependent manner. Similarly, galatrox induced significant neutrophil migration and the release of pro-inflammatory cytokines IL-1α and IL-6 into the mouse peritoneal cavity. Exposure of bone marrow-derived macrophages to galatrox produces pro-inflammatory mediators IL-6, TNF-α, and keratinocyte-derived chemokine (KC) mediated by interaction and activation of TLR4- mediated MyD88-dependent signaling pathway, via its carbohydrate recognition domain. These results suggest that galatrox is able to mediate pro-inflammatory activity by interacting with LacNAc bearing glycans on neutrophils, macrophages and extracellular matrix proteins and inducing the release of pro-inflammatory mediators.
    Glycobiology 06/2014; DOI:10.1093/glycob/cwu061 · 3.75 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Measuring inflammation-induced changes in thresholds of hind paw withdrawal from mechanical pressure is a useful technique to assess changes in pain perception in rodents. Withdrawal thresholds can be measured first at baseline and then following drug, venom, injury, allergen, or otherwise evoked inflammation by applying an accurate force on very specific areas of the skin. An electronic von Frey apparatus allows precise assessment of mouse hind paw withdrawal thresholds that are not limited by the available filament sizes in contrast to classical von Frey measurements. The ease and rapidity of measurements allow for incorporation of assessment of tactile sensitivity outcomes in diverse models of rapid-onset inflammatory and neuropathic pain as multiple measurements can be taken within a short time period. Experimental measurements for individual rodent subjects can be internally controlled against individual baseline responses and exclusion criteria easily established to standardize baseline responses within and across experimental groups. Thus, measurements using an electronic von Frey apparatus represent a useful modification of the well-established classical von Frey filament-based assays for rodent mechanical allodynia that may also be applied to other nonhuman mammalian models.
    Journal of Visualized Experiments 01/2013; DOI:10.3791/51212
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mast cells are important first responders in protective pain responses that provoke withdrawal from intense, noxious environmental stimuli, in part because of their sentinel location in tissue–environment interfaces. In chronic pain disorders, the proximity of mast cells to nerves potentiates critical molecular cross-talk between these two cell types that results in their synergistic contribution to the initiation and propagation of long-term changes in pain responses via intricate signal networks of neurotransmitters, cytokines and adhesion molecules. Both in rodent models of inflammatory pain and chronic pain disorders, as well as in increasing evidence from the clinic, it is abundantly clear that understanding the mast cell-mediated mechanisms underlying protective and maladaptive pain cascades will lead to improved understanding of mast cell biology as well as the development of novel, targeted therapies for the treatment and management of debilitating pain conditions.
    Molecular Immunology 01/2014; 63(1). DOI:10.1016/j.molimm.2014.03.001 · 3.00 Impact Factor


Available from
May 23, 2014